BioTime
Regenerative medicine, reinvented.
Home
Company
About Us
BioTime Video Update Series
Management & Directors
Scientific Presentations
Research Publications
Intellectual Property
Investor Day & Corporate Videos
CEO Blog
Event Calendar
Career Opportunities
Contact Us
Products
Buy Stem Cells
Buy Cell Culture Media
Buy Glycosan Products
Buy SPF Chick Embryo Extracts
Buy Books
Hextend
Investors
Investor Day Brochure
Stock Information
Stock Quote
Stock Chart
Historical Price Lookup
Investment Calculator
Corporate Governance
Highlights
Management & Directors
Committee Composition
Code of Ethics
Contact the Board
Whistleblower Policy
News Releases
Event Calendar
Upcoming Events
Past Events
BioTime Video Update Series
SEC Filings
Fundamentals
Snapshot
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Dividend/Split History
Financial Reports
Investor Presentations
Online Investor Kit
Investor FAQ
Information Request
E-mail Alerts
Contact Information
投资者
Subsidiaries
BioTime Acquisition Corp.
BioTime Asia Ltd.
Cell Cure Neurosciences Ltd.
ES Cell International Pte Ltd
LifeMap Sciences, Inc.
OncoCyte Corp.
OrthoCyte Corp.
ReCyte Therapeutics, Inc.
Regenerative Medicine
You are here:
Home
/ Scientific Presentations
Scientific Presentations
12/04/12
World Stem Cell Summit 2012 Presentation
04/19/12
GTC 8th Stem Cell Summit Presentation.
Novel Technologies in Stem Cell Research
11/01/11
Translation Strategies for Tissue Engineering.
Cells and Matrix: Translational Strategies in the Era of Pluripotency
10/20/11
GTC 5th Advances in Stem Cell Discovery & Development Conference.
hES and iPS cells: Biotechnology Entering a New Era of Com
10/03/11
Regenerative Medicine & Age-Related Degenerative Disease
09/14/11
Stem Cells USA & Regenerative Medicine Congress 2011.
A Roadmap for Successful Commercialization od hES and iPS Cell Based Therapies
07/28/11
Agora Financial Investment Symposium 2011.
The Stem Cell Revolution: Designing First-in-Class Therapies for Age-Related Degenerative Disease
04/12/11
French-American Biotech Symposium (FABS 2011).
Resetting telomere length using transcriptional reprogramming and its application in treatment of age-related degenerative disease.
01/10/11
Stem 2011 Conference